Purchase Order AG32SCP160250
Award Date
9/21/16
Potential Completion Date
12/31/16
Potential Value
$11K
Funding Federal Agency
Northeast Area
Contracting Federal Agency
Central Program Planning Coordination and Support
Awardee
Bioline USA Inc.
Ultimate Awardee
Meridian Bioscience Inc.
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments, is for the provision of laboratory reagents for the Centers for Disease Control and Prevention (CDC) Pittsburgh facility. The contract, valued at $49,466.00, is a firm fixed-price purchase order with an ultimate completion date of November 1, 2024. The contract does not have a set-aside designation. Meridian Bioscience is a key supplier of...
This federal contract award, with an ID of FA860114A0001|0002, was issued by the Air Force Materiel Command (AFMC) to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $94,120.00, is a Blanket Purchase Agreement (BPA) call for the "601396 PREMIER PLATINUM HPSA PLUS" requirement. It is a firm-fixed-price contract with a completion date of May 29, 2016. The contract does not have a...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The $154,150.00 contract is for the delivery of in vitro diagnostic substances, reagents, test kits, and sets, with a period of performance ending on September 30, 2018. There was no set-aside designation used for this award. Meridian Bioscience...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Bioline USA Inc. for the MIC Magnetic Induction qPCR Cycler, associated software, and supplies. The contract has a ceiling value of $13,447.75 and a period of performance through August 18, 2016. No set-aside designation was used for this contract. Bioline USA Inc. is a child company of the parent company...
This is a definitive contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $274,884.11, is for the supply of "PREMIER PLATINUM HPSA PLUS KITS" with a completion date of September 30, 2021. The contract is a firm fixed-price arrangement. Meridian Bioscience Inc. is a key supplier of diagnostic solutions to...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and diagnostic instruments. The contract, valued at $72,684.00, is for the delivery of FY24 base option year Curian HPSA assay products (contract number W81K0023P0057). The contract has a period of performance through September 30, 2026 and was awarded on October 1, 2023. There is no...
This is a firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $19,000.00, is for the delivery of a breath urea analyzer with a period of performance ending on September 4, 2025. The contract was awarded on September 9, 2024 and does not have a...
This is a Firm Fixed Price delivery order awarded by the Defense Contract Management Agency to OEM Concepts Incorporated, a subsidiary of Meridian Bioscience Inc., a for-profit foreign-owned manufacturer of in vitro diagnostic test kits, reagents, and instruments. The $225,441.00 contract is for the purification of polyclonal antibodies, with a completion date of January 25, 2024. The contract has no set-aside designation. Meridian Bioscience has previously served as a prime contractor on...
This is a $6,250,000.00 firm fixed-price definitive contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits and medical testing technologies. The contract is for the Rapid Acceleration of Diagnostics (RADx) Tech Project #6139, which involves the supply of Meridian Bioscience's RevogeneⓇ SARS-CoV-2 assay. This diagnostic test is being procured to support the...
This is a Blanket Purchase Agreement (BPA) call awarded by the Indian Health Service (IHS), a civilian agency, to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits and medical equipment. The BPA call, valued at $181,425.00, is for the procurement of laboratory supplies and an extended warranty for the Meridian Bioscience BREATH ID Smart System. The contract does not have a set-aside designation and has a period of performance through June 16,...